INSIDE CHINA: From knockoffs to knockouts
This article was originally published in Clinica
Executive Summary
In the third article of this China-focused column, Michael Alper of NeuvoMedica takes a look at how China is moving away from being a copycat manufacturer and fast becoming a global medtech innovation hub
You may also be interested in...
INSIDE CHINA: The Hurdles For Medtech Uptake In Emergency Medicine
China still has to overcome significant challenges in the way it manages patients with emergency medical conditions. Michael Alper discusses what these specific challenges are, how they could be limiting the use of medical technology and the steps that are being taken to overcome these hurdles
INSIDE CHINA: The limits of technology leapfrogging
Michael Alper points out where there might be opportunity for growth in China’s rush to embrace new technologies in interventional cardiology
INSIDE CHINA: What new techs are catching the eye of China’s docs?
Michael Alper* shares feedback on the hot technology areas that Chinese doctors are looking into and the factors that impact the technology’s adoption within the clinical community